comparemela.com
Home
Live Updates
Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study ADvance for the Tau PET Tracer [18F]PI-2620 : comparemela.com
Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study "ADvance" for the Tau PET Tracer [18F]PI-2620
Berlin, Germany (PRWEB) January 17, 2023 -- Life Molecular Imaging (LMI) announces today that the first patient has been imaged with [18F]PI-2620 in the
Related Keywords
South Africa ,
Johannesburg ,
Gauteng ,
South African ,
Andrew Stephens ,
Andre Mueller ,
Ludger Dinkelborg ,
Alliance Medical Group ,
Administration Of Neuraceq ,
Johannesburg Stock Exchange ,
Life Healthcare Group ,
Molecular Imaging ,
Life Molecular ,
Chief Medical Officer ,
Life Molecular Imaging ,
Positron Emission Tomography ,
Safety Information ,
Image Interpretation ,
Common Adverse Reactions ,
Piramal Imaging ,
Bayer Pharma ,
Johannesburg Stock ,
Life Healthcare ,
Life Radiopharma ,
Press Release ,
comparemela.com © 2020. All Rights Reserved.